1993 Consensus on growth factor use

Abstract

Healthcare costs could soar if the use of growth factors continues unchecked. In addition, disparities in growth factor approvals between countries has left clinicians with conflicting views on appropriate use. This has led to a perceived need for clinical practice guidelines. In response, eminent haematologists and oncologists came together at the 18th Congress of Chemotherapy in Stockholm, Sweden, last month to discuss when these agents should, and should not, be used.